PBP-W11

General Information


DRACP ID  DRACP02593

Peptide Name   PBP-W11

Sequence  KKLIKVFAKGWKKAKKLFKGIG

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 52% Cytotoxicity=15 µM CellTiter-Blue assay 24 h 1

Hemolytic Activity  Sheep erythrocytes: 0% Hemolysis=15 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02593

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C124H210N32O23

Absent amino acids  CDEHMNPQRSTY

Common amino acids  K

Mass  289200

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  10

Net charge  9

Boman Index  -1150

Hydrophobicity  -32.73

Aliphatic Index  93.18

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  261.9

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30637367

Title  Antimicrobial activity of a porphyrin binding peptide

Doi 110(4):e24074. doi: 10.1002/pep2.24074

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_12364

DRACP is developed by Dr.Zheng's team.